These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9396398)

  • 1. Retinoblastoma protein and proliferating-cell nuclear antigen expression as predictors of recurrence in well-differentiated papillary thyroid carcinoma.
    Omura K; Nagasato A; Kanehira E; Kinsen H; Amaya S; Kimura K; Kajita T; Nozaki Y; Mizukami Y; Nonomura A; Watanabe Y
    J Clin Oncol; 1997 Dec; 15(12):3458-63. PubMed ID: 9396398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p21 ras protein as a prognostic factor in papillary thyroid cancer.
    Basolo F; Pinchera A; Fugazzola L; Fontanini G; Elisei R; Romei C; Pacini F
    Eur J Cancer; 1994; 30A(2):171-4. PubMed ID: 7908818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual specificity phosphatase 6 as a predictor of invasiveness in papillary thyroid cancer.
    Lee JU; Huang S; Lee MH; Lee SE; Ryu MJ; Kim SJ; Kim YK; Kim SY; Joung KH; Kim JM; Shong M; Jo YS
    Eur J Endocrinol; 2012 Jul; 167(1):93-101. PubMed ID: 22535643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Bax, p53, and p27/kip in patients with papillary thyroid carcinoma with or without cervical nodal metastasis.
    Karlidag T; Cobanoglu B; Keles E; Alpay HC; Ozercan I; Kaygusuz I; Yalcin S; Sakallioglu O
    Am J Otolaryngol; 2007; 28(1):31-6. PubMed ID: 17162129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maspin in thyroid cancer: its relationship with p53 and clinical outcome.
    Boltze C; Schneider-Stock R; Meyer F; Peters B; Quednow C; Hoang-Vu C; Roessner A
    Oncol Rep; 2003; 10(6):1783-7. PubMed ID: 14534696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of monocyte chemotactic protein-1 in papillary thyroid carcinoma is correlated with lymph node metastasis and tumor recurrence.
    Tanaka K; Kurebayashi J; Sohda M; Nomura T; Prabhakar U; Yan L; Sonoo H
    Thyroid; 2009 Jan; 19(1):21-5. PubMed ID: 19072670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of cyclin E, retinoblastoma protein, and p21Cip1/WAF1 immunostaining in the oncogenesis of papillary thyroid carcinoma.
    Brzeziński J; Migodziński A; Toczek A; Tazbir J; Dedecjus M
    Clin Cancer Res; 2005 Feb; 11(3):1037-43. PubMed ID: 15709169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of the expression of major histocompatibility complex class II antigen, HLA-DR and -DQ, with recurrence of papillary thyroid cancer.
    Jo YS; Lee JC; Li S; Choi YS; Bai YS; Kim YJ; Lee IS; Rha SY; Ro HK; Kim JM; Shong M
    Int J Cancer; 2008 Feb; 122(4):785-90. PubMed ID: 17957790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of the apoptotic index analysed jointly with selected cell cycle regulators and proliferation markers in non-small cell lung cancer.
    Dworakowska D; Jassem E; Jassem J; Karmoliński A; Lapiński M; Tomaszewski D; Rzyman W; Jaśkiewicz K; Sworczak K; Grossman AB
    Lung Cancer; 2009 Oct; 66(1):127-33. PubMed ID: 19200616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of pituitary tumour-transforming gene-binding factor (PBF) expression in papillary thyroid carcinoma.
    Hsueh C; Lin JD; Chang YS; Hsueh S; Chao TC; Yu JS; Jung SM; Tseng NM; Sun JH; Kuo SY; Ueng SH
    Clin Endocrinol (Oxf); 2013 Feb; 78(2):303-9. PubMed ID: 22888961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferating cell nuclear antigen expression in papillary thyroid carcinoma.
    Ando H; Funahashi H; Ito M; Imai T; Takagi H
    J Clin Pathol; 1996 Aug; 49(8):657-9. PubMed ID: 8881917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.
    Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ
    Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiated thyroid carcinomas from children and adolescents express IGF-I and the IGF-I receptor (IGF-I-R). Cancers with the most intense IGF-I-R expression may be more aggressive.
    Gydee H; O'Neill JT; Patel A; Bauer AJ; Tuttle RM; Francis GL
    Pediatr Res; 2004 Apr; 55(4):709-15. PubMed ID: 14973173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infiltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults.
    Gupta S; Patel A; Folstad A; Fenton C; Dinauer CA; Tuttle RM; Conran R; Francis GL
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1346-54. PubMed ID: 11238531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.
    Chou CK; Yang KD; Chou FF; Huang CC; Lan YW; Lee YF; Kang HY; Liu RT
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E196-205. PubMed ID: 23264400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
    Rivera M; Ghossein RA; Schoder H; Gomez D; Larson SM; Tuttle RM
    Cancer; 2008 Jul; 113(1):48-56. PubMed ID: 18484584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor expression in invasive papillary thyroid carcinoma.
    de Araujo-Filho VJ; Alves VA; de Castro IV; Lourenço SV; Cernea CR; Brandão LG; Ferraz AR
    Thyroid; 2009 Nov; 19(11):1233-7. PubMed ID: 19888861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.